Summary Surfactant protein-A enhances the phagocytosis and killing of many pathogens, although studying this effect in an assortment of models and different experimental protocols has sometimes yielded conflicting results. In this report, using the human THP-1 cell line as the primary phagocytic cell, we systematically examined several models where microspheres, Staphylococcus aureus and Escherichia coli were used for targets. We found that SP-A derived from human lavage appeared to enhance phagocytosis by two different mechanisms; by SP-A binding of the target to enhance its recognition and subsequent phagocytosis and by a direct SP-A stimulatory effect on the phagocyte itself. Both SP-A mechanisms occurred with different targets in the same experimental system and the SP-A effects were qualitatively (but not quantitatively) comparable in several human cell lines (THP-1, U937, Mono-Mac-6). We also found that the SP-A effects were abrogated when SP-A was combined with surfactant lipids, but the lipids did not affect the basal level of phagocytosis or phagocytosis by mechanisms not involving SP-A. Moreover, the stimulatory effect of SP-A was pH-dependent and appeared to be independent of several other phagocytic mechanisms, including those mediated by Fc receptors and mannose receptor.
Introduction
Surfactant is a complex material that confers mechanical stability to the distal lung and has a role in the regulation of pulmonary host defense. [1] [2] [3] It consists of approximately 90% lipids and 5-10% protein. The best studied and most abundant of the protein components is surfactant protein-A (SP-A), a collagenous lectin or collectin. Other members of the collectin family include SP-D, mannose binding protein, conglutinin, and collectin-43. 4 The complement protein C1q has a structure similar to that of mannose binding protein and SP-A, and although it does not have a lectin or carbohydrate recognition domain (CRD), it is often grouped with the collectins. SP-A is an oligomeric glycoprotein with a monomeric molecular mass of 28-35 kDa. It is synthesized and secreted by alveolar type II cells, by cells of the tracheal and bronchial submucosal glands, and in some species by nonciliated bronchiolar epithelial cells. [5] [6] [7] [8] The collectins, SP-A and SP-D, are thought to play a variety of important roles in the defense of the lung, including enhancing phagocytosis. SP-A has been studied extensively. In vitro studies have shown that SP-A can stimulate phagocytosis and killing of various pathogens by alveolar macrophages, such as Escherichia coli, Staphylococus aureus, Streptococcus pneumoniae and Haemophilus influenzae.
2,9-12 SP-A may exert these actions by serving as an opsonin, by activating the macrophage directly, or by both of these mechanisms. 10, 13, 14 It has been assumed that in most cases the lectin or CRD of SP-A binds to glycoconjugates on the surface of the involved particle or pathogen and that this binding enhances the interaction between the particle or pathogen and the cell surface of the phagocyte. SP-A has been shown to bind a variety of ligands including: LPS, lipoteichoic acid, peptidoglycan, lipids, glycolipids, as well as a variety of carbohydrates, [15] [16] [17] [18] and these interactions may mediate the SP-A effect on the enhanced uptake of Gram negative bacteria, Gram positive bacteria, viruses, fungi, pollen grains, and some mineral particulates. [1] [2] [3] 9, 14, 19, 20 Although in most studies the SP-A effect on phagocytosis has been reported to be stimulatory, 1, 3, 21 there is also evidence that in some situations or with certain organisms SP-A does not enhance phagocytosis. 9, 19, 22, 23 In previously published studies a variety of experimental conditions, assays, phagocytic cells, and species, as well as a very broad assortment of microorganisms have been used in different investigations. However, the process of phagocytosis is complex and may be affected by multiple factors. [24] [25] [26] Examples of such factors include: (a) the characteristics of the phagocytic cells; such as their identity, degree of activation, population of cell surface receptors, and the local conditions with respect to pH and ionic composition; (b) the characteristics of the pathogen; including its identity, proliferation state, and the nature of the pathogen-associated molecular patterns (PAMPs) on its surface; (c) the nature of other accessory molecules and opsonins available; including immunoglobulins, complement, other opsonins (such as the mannose binding lectin) and soluble receptors, including soluble forms of the mannose receptor and CD14; (d) speciesspecific mechanisms by which phagocytes kill microorganisms. 27, 28 Therefore, this kind of complexity underscores the need for caution in arriving at conclusions about mechanisms involved in SP-Amediated phagocytosis. [1] [2] [3] The purpose of the present study was to systematically examine the ability of human SP-A to modulate phagocytosis in a human cell culture system that would be: (a) free from problems associated with the routine procurement of samples from human subjects; (b) employ a human cell line and (c) eliminate potential problems due to species differences. For example, a well-characterized human cell culture system may overcome issues relating to the limited number of cells obtainable from volunteers, their heterogeneity (even in the same individual), and potential differences in both basal and stimulated levels of activity in cells from different individuals. Although some of the experimental variables examined here have been examined previously by others, most single studies examined a subset of the variables we studied in this report making it difficult to determine whether certain observations are cell-or system-specific. In addition, nearly all of the published work has used pooled rat alveolar macrophages and human SP-A. Although cells from rats may be more uniform than those from humans, inter-and intra-individual variability as well as species differences between rats and humans 28 in macrophage activity may be issues.
In the present study, we examined and compared variables in a single system with the same assays using human SP-A and the human THP-1 cell line as the primary phagocytic cell. Following differentiation with either phorbol myristate acetate (PMA) or vitamin D 3 , THP-1 cells are actively phagocytic and have many properties that resemble those of macrophages. As targets for phagocytosis we used fluorescent microspheres (beads) and two types (one Gram negative and one Gram positive) of fluorescently labeled bacteria. The use of microspheres is advantageous and provides a simplified model because it eliminates concerns about bacterial growth stage-dependent changes 9 in surface properties. Also, the use of this simplified model eliminates concerns as to which of the multiple different moieties on the bacterial surface (lipopolysaccharide (LPS), lipoteichoic acid, peptidoglycan or other cell surface carbohydrates) are mediating the binding of SP-A or of cell surface molecules. Using these model systems we studied phagocytosis with regard to molecules (i.e. receptors) and/or pathways involved, as well as the effect of pH and of surfactant lipids on phagocytosis.
Materials and methods

Media and reagents
RPMI 1640 culture medium, L-glutamine, antibiotic-antimycotic solution (Penicillin G, streptomycin sulfate, Amphotericin B), trypan blue, human immunoglobulin G (IgG), mannose, and PMA were obtained from Sigma Chemical (St. Louis, MO) and low-endotoxin fetal calf serum (FCS) was obtained from BioWhittaker (Walkersville, MD). Paraformaldehyde was obtained from Ladd Research Industries (Burlington, VT) and vitamin D 3 from Biomol (Plymouth Meeting, PA). Survanta (beractant intratracheal suspension; Ross Products Division, Abbott Laboratories, Columbus, OH) was used as a source of surfactant lipid. Survanta is a preparation derived from cow lung homogenate. It consists of more than 95% lipids with a small amount of the hydrophobic surfactant proteins, SP-B and SP-C. Survanta contains no SP-A. Fluorescent carboxylate-modified polystyrene microspheres or beads (FluoSpheres s ), the fluorescently labeled bacteria and the specific antibodies to them used in some studies, and fluorescein-5-isothiocyanate, isomer I (FITC) were purchased from Molecular Probes Inc., Eugene OR).
Isolation of SP-A
SP-A was prepared from alveolar proteinosis lavage by two methods to eliminate concerns that SP-A effect was an artifact of a specific preparation procedure. The protein preparations obtained by these two methods displayed nearly identical properties in the assays utilized here. In one method we used preparative isoelectric focusing (Rotofor, Bio-Rad, Hercules, CA) to purify SP-A. This method has been thoroughly described elsewhere. 29 Butanol extraction of the same alveolar proteinosis lavage material was also used to prepare SP-A. This method has been described in detail. 30 All of the data presented in this report were obtained with SP-A obtained via butanol extraction, although SP-A prepared by isoelectric focusing gave the same results (data not shown). The purified protein from these methods was examined by two-dimensional gel electrophoresis and silver staining and found to be greater than 99% pure. The content of endotoxin was determined with the QCL-1000 LAL assay (BioWhittaker, Walkersville, MD). This test indicated an average endotoxin content of less than 3 pg LPS/mg SP-A. SP-A was stored at a concentration 1 mg/ml in Hank's Balanced Salt Solution (pH 7.4) at -801C. Although all of the data presented in this report were prepared with SP-A isolated from a single alveolar proteinosis patient, we performed some experiments with SP-A isolated from at least three other alveolar proteinosis cases, normal human lung lavage, and with SP-A from an in vitro expression system. 29, 31 Cell culture 
Labeling of bacteria by fluorescein isothiocyanate (FITC)
S. aureus and E. coli from log phase cultures (4 h incubation) were collected by centrifugation at 3000 rpm for 10 min and washed with 50 ml phosphate-buffered saline (PBS). The bacteria were heat-killed in a water bath at 951C for 10 min and were resuspended in 10 ml of 0.1 M sodium carbonate buffer (pH 9.0) at a density of 4.5 Â 10 9 bacbacteria/ml. Fluorescein isothiocyanate (FITC) from a 10 mg/ml stock solution in dimethyl sulfoxide (DMSO) was added to a final concentration of 0.175 mg/ml. Bacterial labeling was done for 1 h at room temperature with continuous shaking while protected from light. The bacteria were subsequently centrifuged at 2000 Â g for 10 min and washed with 50 ml PBS three times or until the supernatant was clear. Bacteria were resuspended in RPMI 1640 without FCS to a final concentration of 1 Â 10 9 /ml by determining optical density at 660 nm in a spectrophotometer. Aliquots of 1 ml of bacterial suspension were placed in microcentrifuge tubes, dried by lyophilization and stored at -201C.
SP-A enhanced phagocytosis measured by flow cytometry
Vitamin D 3 -differentiated THP-1 cells were washed once with PBS and resuspended in fresh serum-free RPMI1640 at a density of 1 Â 10 6 cells/ml. Some experiments were also done with U937 and MonoMac-6 cells under identical conditions. Microspheres were prewashed then diluted with serumfree RPMI1640 at a density of 2.5 Â 10 9 beads/ml. The ratio of microspheres to THP-1 cells was 50:1 in each experiment. Microspheres were vortexed for several seconds before experiments. For some experiments microspheres were preincubated with 25 mg/ml SP-A for 15 min at 371C, washed three times with serum-free RPMI1640, then added to the THP-1 cells. Microspheres without SP-A served as a control. At given intervals cells were harvested and unbound microspheres washed away with PBS. These experiments were performed in the absence and in the presence of serum and comparable results were obtained under both conditions (data not shown), although the magnitude of the cell-associated fluorescence in the presence of serum was greater. However, in the absence of serum the THP-1 cells became increasingly adherent, complicating analysis by FACS. To overcome adherence problems we reduced serum concentrations from 10% to 0.5% (which we used in these experiments) with little effect on the amount of cell-associated fluorescence under a given set of conditions (data not shown).
Cells were fixed with freshly prepared 1% paraformaldehyde on ice for 30 min in the dark and then each sample washed three times with wash-buffer (PBS, 1% bovine serum albumin, 0.02% sodium azide). Samples were resuspended in wash buffer and kept in the dark at 41C until FACS was performed. Because the fluorescent label on the microspheres is within the matrix of the bead as well as on its surface, it is not possible to quench their fluorescence completely in order to distinguish between externally bound and internalized microspheres. However, in the bacterial studies described later we were able to describe phagocytosis because we could distinguish between particles bound to the phagocytic cell surface and those that had been internalized by quenching the external fluorescence with trypan blue. Therefore, in the microsphere experiments cell-associated fluorescence is referred to simply as cell-associated fluorescence or binding, whereas in the bacterial experiments we refer to total fluorescence as cellassociated fluorescence and the fluorescence that remains after trypan blue treatment is taken to represent internalization and is referred to as phagocytosis.
SP-A enhanced phagocytosis using a plate microfluorometric assay THP-1 cells were differentiated for 24 h by 10 -8 M PMA in black Costar clear-bottom 96 well plates. Each well contained 200 ml of medium with THP-1 cells at a density of 1 Â 10 6 cells/ml. After differentiation, the cells were washed with PBS and the medium replaced with serum-free RPMI1640. E. coli K-12 or S. aureus 25923 were preincubated with 25 mg/ml SP-A for 15 minutes at 371C in serum-free RPMI1640. The SP-A bound bacteria were washed to remove unbound SP-A and resuspended in serumfree RPMI1640 at a final density of 1 Â 10 8 bacteria/ ml or a 100:1 bacteria:cell ratio. Binding of the SP-A directly to the bacteria was confirmed by eluting the washed bacteria with SDS sample buffer, running the eluted proteins on SDS gels, and immunostaining with an SP-A antibody (data not shown). 32 At the conclusion of each experiment phagocytosis was stopped by the addition of ice cold PBS and unbound bacteria washed away. The fluorescence in each well was measured at an excitation wavelength of 485 nm and an emission wavelength of 530 nm using a 7630 Microplate Fluorometer (Cambridge Technology, Inc.). The plate fluorometric assay requires the use of fewer cells and smaller quantities of stimulatory or modulating agents and allows us to test many more conditions at a time than the FACS-based assays do. For the plate assay, PMA-differentiated THP-1 cells were used, because PMA-differentiated THP-1 cells are adherent to a microtiter plate. All incubations and washes were done in the plate, including the incubation with trypan blue to quench external fluorescence, which allows for measurement of internalized fluorescence or phagocytosis.
Trypan blue treatment
After an initial fluorometric reading, 200 ml of trypan blue (0.25 mg/ml, pH 4.4) was added to each sample to quench the external fluorescence, and the plate was read again to measure the amount of internalized fluorescence.
Flow cytometry
Flow cytometric analyses were performed with a FACScan (Becton Dickinson Mountain View, CA). Relative fluorescence was measured in 1 Â 10 4 cells per sample. Data were acquired and processed using the Cellquest software Cell Quest Version 3.1f or FACS Analysis WinMDI Version 2.8.
Statistical analysis
Data were analyzed using SigmaStat (SPSS Inc., Chicago, IL) with a Po0.05 considered significant. In most cases statistical comparisons were made using a one way analysis of variance (ANOVA) with the Bonferroni correction for multiple comparisons with a Po0.05 considered significant. In time course experiments experimental points were compared with controls at the same time point using a t-test. Differences between experimental values and control points were considered significant when Po0.05.
Results
Binding of microspheres
The first series of experiments was done to assess the role of SP-A in phagocytosis using fluorescent microspheres. Cell-associated fluorescence was quantified by FACS analysis and included both externally bound and internalized microspheres.
We first performed a time course experiment in which SP-A (25 mg/ml) and the fluorescent microspheres were added to the THP-1 cells for time periods ranging from 30 min to 3 h (Fig. 1) . The difference between SP-A enhanced binding and controls continued to increase for the duration of the experiment. However, we selected the 2 h time point to conduct a dose response study using doses of SP-A ranging from 5 to 50 mg/ml (Fig. 2) for most of our studies. Although there was a dose-dependent increase in SP-A-stimulated binding throughout the tested concentrations, we used a dose of 25 mg/ml in subsequent studies because this resulted in a less than maximal effect so that both stimulatory and inhibitory influences could be detected in other experiments.
Role of surfactant lipids
In this series of experiments, lipid (in the form of Survanta) was preincubated with SP-A (25 mg/ml) for 30 min at 371C and the mixture added to the THP-1 cells at the same time as the microspheres. In negative control samples only SP-A or only microspheres were added to the THP-1 cells. Doses of lipid ranging from 1000 mg/ml down to 50 mg/ml caused a reduction in phagocytosis from levels that would have been seen if the SP-A was added alone. However, at lipid concentrations below 200 mg/ml stimulation over control levels was still evident (Fig. 3) . At the highest dose of lipids (1000 mg/ml) levels of cell-associated fluorescence were equivalent to those seen in the absence of SP-A, suggesting that the lipid affected only the SP-A mediated stimulation and not basal levels of cell-associated fluorescence (binding and internalization).
SP-A as an opsonin or an activation ligand
We used several different conditions for incubation of SP-A with the microspheres and the THP-1 cells. As shown in Fig. 4 , the control for these experiments was cells incubated with microspheres alone (group 1). We preincubated microspheres for 15 min at 371C in SP-A (25 mg/ml), removed unbound SP-A by washing and centrifugation of the microspheres and then added the SP-A preincubated microspheres to THP-1 cells (group 2). In parallel we used microsphere suspensions that were preincubated without washing away any unbound SP-A (group 4). We also added microspheres and SP-A simultaneously to THP-1 cells (no preincubation, group 3). In this series of experiments, we found that SP-A is capable of increasing cell-associated fluorescence in all cases (Fig. 4) . However, the greatest effect was seen in cases where the target microspheres were preincubated with SP-A and the unbound SP-A remained in the incubation medium (group 4, Fig. 4 ). Moreover, in group 4 the effects of SP-A appeared to be additive of those in groups 2 and 3. In the studies reported here, the SP-A concentration mixed with the microspheres was 25 mg/ml. Although we did not measure the relative amounts of microsphere-bound SP-A and ''free'' SP-A in these experiments we have shown in previous publications that SP-A can enhance TNF-a levels or activation of NF-kB within 1 h at doses or 10 mg/ml or less. 29, 33 A similar effect of SP-A on activation of macrophages, in addition to its opsonic role, has been demonstrated in macrophages from SP-A-/-mice. 34 
ARTICLE IN PRESS
Phagocytosis of bacteria
The next series of experiments was done to assess the role of SP-A in the binding and uptake of certain bacteria. The bacteria were labeled with FITC and binding and phagocytosis were assessed using two different methods, the FACS method used in the fluorescent microsphere experiments, and a plate fluorometric assay. The first set of experiments was a time course study using bacteria that were preincubated in 25 mg/ml of SP-A, as we used in most of the microsphere experiments. We performed experiments with both S. aureus (Fig. 5 ) and E. coli (Fig. 6) . In time points ranging from 15 min to 3 h we found that SP-A enhanced both the total THP-1 cell-associated fluorescence (Figs. 5A and 6A) and the internalized fluorescence measured after trypan blue quenching of external fluorescence (Figs. 5B and 6B ). SP-A dose response studies with both types of bacteria using SP-A doses of 2.5-100 mg/ml, were performed using FACS (not shown) and the results were equivalent to those obtained with the plate fluorometric assay. We chose an SP-A dose of 25 mg/ml for subsequent studies (as we did with the fluorescent microsphere studies). The data from these experiments (a) confirm previous studies of binding and phagocytosis of bacteria, (b) indicate that the stimulatory effect of SP-A can occur with both bacteria and microspheres, and (c) show that in the bacterial studies the stimulatory effect was on both binding to the cell surface and internalization.
SP-A effects on phagocytosis by other monocytic cell lines
To assess cell specificity, we did a series of comparison studies in which, in addition to the THP-1 cell line, we used two other cell lines, U937 cells and Mono-Mac-6 cells (Fig. 7) . Published studies with these monocytic cell lines have used a variety of conditions, including no additional differentiation step, differentiation with either PMA or vitamin D 3 , or with other substances. [35] [36] [37] [38] We used differentiated cells for these studies. Furthermore, we examined the SP-A effect in the presence of 0.5% FCS and in the absence of serum. In all cases the background fluorescence was roughly equivalent, but control (no SP-A) levels of phagocytosis of labeled S. aureus, while nearly identical in U937 and Mono-Mac-6, were approximately twice as high in THP-1 cells (hatched bar) in both the presence and the absence of serum (Fig. 7) . When the bacteria were preincubated in 25 mg/ml of SP-A and washed before addition to the cells, increased levels of cell-associated fluorescence were seen in all cases. However, there were much greater increases when SP-A and the bacteria were added simultaneously to the cells. This finding was similar to that seen in the microsphere experiments (Fig. 4) . These data indicate that although the general properties of these cell lines are similar, the magnitude of response differs among them.
Opsonization with SP-A versus specific antibody
To assess whether SP-A could affect phagocytosis of bacteria mediated by the binding of the immunoglobulin in an E. coli specific antibody to Fc receptors directly or indirectly through activation of the macrophage we did the following set of experiments (Fig. 8) . As described above, when we preincubated E. coli with SP-A and washed away unbound SP-A we observed an approximate 2-fold increase in phagocytosis (group 3) versus unopsonized bacteria (group 2). As expected, further increases occurred when we did not wash away unbound SP-A after preincubation (group 4) or when we added SP-A and E. coli simultaneously to the THP-1 cells (group 5). These groups were analyzed statistically by ANOVA with the Bonferroni correction and the results are indicated in column D. We also compared the same set of samples (column C) by designating the SP-A pre-incubation and wash group (group 3) as the control sample and comparing it to the samples where there was no washing to remove unbound SP-A (groups 4 and 5). Both of these groups had significantly higher binding than group 3, where unbound SP-A was washed away. All of the incubations including antibody (groups 6-8) were significantly increased over those of E. coli alone (group 2) (column B). However, although the degree of phagocytosis of antibody-opsonized (preincubated) E. coli (group 6) was significantly greater than that with E. coli alone (group 2). Moreover, if the antibody-opsonized bacteria were also preincubated with SP-A (group 7) or if SP-A was added when the bacteria were added to the cells (group 8), no significant change in cell-associated fluorescence was seen in these cells versus cells incubated with E. coli with antibody alone (group 6) (column A). This suggests that Fc-receptor mediated phagocytosis was not affected by either the activation of the THP-1 cells resulting from SP-A in the medium (group 8) not bound to the bacteria, or by SP-A bound to the bacteria during pre-incubation (group 7). However with both of these types of SP-A treatments levels of binding and phagocytosis of bacteria increase (Fig. 8, groups 4 and 5; Fig. 4, groups 3 and 4) .
ARTICLE IN PRESS
Role of other factors in SP-A induced binding
To determine whether receptors known to be involved in phagocytosis are also involved in the SP-A response observed in the system under study, we attempted to reduce the number of available receptors by preincubating THP-1 cells in several ligands for these receptors (Fig. 9) . The conditions we employed have been used in studies published . E. coli were preincubated with either antibody to E. coli alone (group 6) or with SP-A (group 4), washed, and added to THP-1 cells for 1 h. In some cases SP-A was added to the antibody-bacteria mixture for a 15 min preincubation period after which the unbound SP-A was either washed away (group 7) or allowed to remain in the incubation mixture when it was added to THP-1 cells (group 8). Phagocytosis was assessed by FACS after 1 h and the mean 7SEM are shown. To analyze the data from this experiment we performed several different statistical tests. In each case we used a one way ANOVA with the Bonferroni correction to make multiple comparisons versus a control group. For each test, the control group is indicated by the (C) in the columns on the left of the figure (labeled A, B, C, and D), treatment groups that are significantly different (Po0.05) from the control group are marked with an ( * ), and those that are not significantly different are marked with a dash (-). If no marking appears in the column, that group was not included in the statistical comparison. For example, in column A, group 6 was designated the control sample and compared to groups 2, 7, and 8. Group 2 was significantly different from the control group (group 6), but groups 7 and 8 were not. by other investigators investigating these receptors. We used 50 mg/ml of human IgG to react with Fc receptors and 10 mg/ml of mannose to compete with binding by the mannose receptor. 39 We chose microspheres as a target for these studies because of their simplicity, since they are devoid of molecules and potential ligands for phagocytic receptors that are present on bacteria. Neither of these had much of an effect on SP-A activity. We also examined the effect of pH on the SP-A stimulation of binding of microspheres. Using medium at pH 7.5, 6.5, and 5.5 we found that the SP-A effect decreased as the pH decreased (Fig.  10) . The pH of the alveolar hypophase under normal conditions is thought to be 6.9. 40 
Discussion
Phagocytosis in the lung occurs through a variety of diverse processes that effectively clear different targets, including particles, pathogens, and apoptotic cells, from the alveolar spaces. Different cell surface receptors on the phagocytic cells can recognize diverse components on the targets directly or via host-derived adapter molecules that bind to different surface components. [24] [25] [26] These receptors may include Fc receptors, mannose receptors, and complement C1q receptors, all of which have been demonstrated to be expressed on THP-1 cells. [41] [42] [43] Interaction between these microbial surface components and the receptors on the phagocytic cells results in binding of the target by the phagocytic cell, followed by its internalization. The events following internalization are also diverse. [24] [25] [26] Adding to the complexity of phagocytosis is the fact that some or all of these processes can be altered depending on the recent activities of the cell or changes in its microenvironment.
Therefore, in this study we examined, in a systematic way, the role of SP-A in phagocytosis and tried to gain insight into the molecules and factors involved by studying multiple targets and receptors in a single human cell type with the same experimental protocols. We studied interactions of SP-A (prepared by two different methods) with polystyrene microspheres to eliminate concerns about the growth stage of the bacteria or the method of sample preparation. We believe that the amounts of SP-A we have used in our studies are within physiological ranges. This is based on several assumptions that have been made by various laboratories. BAL levels of SP-A in normal individuals are estimated to be in the range of 2-10 mg/ ml and are likely to have been diluted 10-100 fold by the lavage procedure. 44, 45 However, in the normal lung, 95% of this SP-A is thought to be lipid-associated and probably inactive in terms of influencing phagocytic events. 46, 47 The amount of SP-A is about 2-5% that of the surfactant lipids so the amounts of lipid added are also within physiological ranges.
We also studied: (a) two kinds of bacteria; S. aureus, as a representative Gram positive bacterium, and E. coli as a representative enhancement of phagocytosis by SP-A can occur whether SP-A is bound to Gram negative bacteria, presumably by LPS, or to Gram positive bacteria, 15 where the interaction is probably with lipoteichoic acid. 18 It is important to note that although we saw positive effects on both types of bacteria used here, variable effects have been noted in other studies depending upon the growth stage of a specific strain of bacteria strain 9 or different strains of the same bacteria. 15, 48 There have also been reports of pathogens whose clearance is not affected by SP-A. 19, 22, 23 The SP-A mediated effect appeared to be sensitive to pH changes, and Fc or mannose receptors were not the primary mediators in this system as has been reported in other systems. 49 Moreover, the SP-A mediated effects were qualitatively the same in several different human monocytic cell lines, although quantitative differences were observed. Furthermore, the surfactant lipids inhibited SP-A-induced binding of targets without affecting basal levels. The precise underlying mechanisms are not known but the process is rapid, being apparent as early as 30 min after addition of SP-A or an SP-A-coated target particle, as are many other SP-A actions. 1 The rapidity of the effect suggests that the stimulatory effect is probably the result of new protein or RNA synthesis or due to the secretion or action of cytokines.
With both types of bacteria and with the microspheres there was an SP-A dose-dependent enhancement of binding by the THP-1 cells including, at least in the case of the bacteria, both cell surface binding and internalization. However, much of this effect was negated in the presence of added surfactant lipid, although surfactant lipid addition had no impact on basal levels of binding, indicating that the inhibitory effect of surfactant lipid on SP-A-mediated events is specific to SP-A. Surfactant lipids have been shown to abrogate other SP-A effects, 1 including activation of NF-kB, 33 modulation of cytokine production, [50] [51] [52] cell surface marker expression, 53 and immune cell proliferation 51 and fibroblast function. 54 Furthermore, the surfactant lipid effect on cytokine production by THP-1 following treatment with factors other than SP-A alone, was to a lesser extent than that observed following treatment with SP-A 55 or with SP-A and bleomycin. 50 Presumably, the lipid and SP-A combine to form surfactant lipoprotein complexes and the complexed SP-A is then unable to interact with the target particle. This observation raises some question about the importance of the SP-A effect on phagocytosis in normal lung, where, as mentioned above, more than 95% of the SP-A is thought to be complexed with lipid. However, this could indicate that the SP-A effects on phagocytosis become more important in the lung when there are alterations in surfactant composition, particularly if the amount of SP-A is increased. 45 The increased susceptibility of SP-A null mice to infection with several microorganisms seems to reaffirm the importance of SP-A in the clearance of these organisms from the lung. 56 But SP-A exerts multiple effects on phagocytic cells, including effects on levels of activity and cell surface molecule expression, as well as on chemotaxis and oxygen radical production 34, 57 so it is difficult to distinguish whether the increased susceptibility to infection is directly or indirectly due to the absence of SP-A. For example, the increased susceptibility may be due to the deficiency in the ability of the macrophage to clear bacteria; perhaps a consequence of deficient macrophagepriming by SP-A, as would be the case in the SP-A -/-mouse but not in the wild type. In fact, macrophages from the SP-A knockout mouse exhibit decreased macrophage function including bacterial killing and reactive oxidant generation. 34, 57 Another reason for the decreased macrophage function in the SP-A knockout mice may be the lack of the normal stimulatory influence exerted by SP-A on the expression of cell surface markers. 53 The SP-A effect does not appear to be cell line specific as assessed by the results from the three different monocytic cell lines, the THP-1 line, the U937 line, and the Mono-Mac-6 line, used here. However, differences in the magnitude of the response were observed. Many studies involving these cells employ vitamin D 3 , phorbol myristate acetate, or some other agent to further differentiate the cells. 36, 38, 58 We found that the phagocytic behavior of all three lines was similar and that differentiation with vitamin D 3 , while slightly increasing the amount of phagocytosis, had no effect on the nature of the response. In this context the role of serum proteins on the SP-A effect appeared to affect the magnitude of the response (greater in the presence of serum), but not the quality of the response (i.e. the response pattern). The generalized increases in the presence of serum suggest a non-specific activation of the cells, rather than a specific interaction with SP-A, and that addition of SP-A enhances the process of phagocytosis.
Other investigators have implicated various receptors in mediating the SP-A effect, such as the SP-A receptor, 59 the mannose receptor 49 or the C1q receptor. 60, 61 ''The present study assessed the potential interaction of the SP-A-specific mechanism with other phagocytic mechanisms. There did not appear to be any change in the SP-A-mediated effect after modulating the activity of mannose receptors and Fc receptors, suggesting that these receptors do not play a role in the enhancement of phagocytosis by SP-A in this system.'' There was also no evidence that the activation effect of SP-A had any influence on antibodymediated phagocytosis. Therefore, the SP-A mediated effects in the THP-1 cell culture system may be occurring via an SP-A receptor or by other pattern recognition receptors involved in innate immune processes. Evidence has been published that SP-A can interact with Toll-like receptors. 62, 63 The presence of an SP-A receptor has not been documented in all of the cells used here, although it is expressed in the U937 cell line. 64 Alternatively, SP-A may interact with other cell surface molecules that have not yet been identified. Moreover, because the SP-A effect was diminished at acidic pH, it is possible that pH changes in the local environment, as may occur in some disease states, may compromise phagocytosis and further contribute to disease progression.
In summary, we systemically examined the ability of SP-A to modulate phagocytosis in a human cell culture system. In this system; (a) SP-A was found to exert similar stimulatory effects on the binding and internalization of fluorescent microspheres, Gram positive and Gram negative bacteria both by enhancing the recognition of these targets by phagocytic cells, and by exerting a direct stimulatory effect on these cells. (b) Comparable findings were observed for other cell lines used as phagocytic cells, although the THP-1 cell line showed higher levels in certain cases. (c) Surfactant lipids abrogated the SP-A enhanced effect on phagocytosis but had no effect on basal levels. (d) Under the conditions employed here the SP-A-mediated effects were sensitive to pH changes and specific to SP-A rather than to an enhancement of other known phagocytic mechanisms involving Fc or mannose receptors, although there does seem to be an interaction between SP-A and the C1q receptor.
